Budget and Appropriations Status

The Further Consolidated Appropriations Act, 2024 (H.R.2882), provides NCI a total appropriation of $7.22 billion, an increase of $120 million compared to the interim budget provided under the Continuing Resolution.

The final year of new appropriations for the NCI component of the Cancer Moonshot was 2023, which provided an additional $216 million. The net difference in NCI’s funding for FY 2024 compared to FY 2023 is a decrease of $96 million.